Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid Congress
14 juin 2024 07h30 HE
|
Aptose Biosciences, Inc.
Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid Congress
Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
03 juin 2024 16h30 HE
|
Aptose Biosciences, Inc.
Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market
Under Nasdaq Rules
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
31 mai 2024 08h00 HE
|
Aptose Biosciences, Inc.
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
FUJIFILM Dimatix refuerza su amplia cartera de cabezales de impresión de inyección de tinta con la presentación de FUJIFILM Dimatix SKYFIRE® SF600 en drupa 2024
29 mai 2024 09h59 HE
|
FUJIFILM Europe GmbH
LEBANON, Nuevo Hampshire, May 29, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Dimatix, Inc., fabricante y proveedor líder mundial de cabezales piezoeléctricos de inyección de tinta industrial gota a gota, ha...
Aptose Reports Results for the First Quarter 2024
14 mai 2024 16h01 HE
|
Aptose Biosciences, Inc.
Aptose Reports Results for the First Quarter 2024
Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024
06 mai 2024 16h30 HE
|
Aptose Biosciences, Inc.
Aptose to Report First Quarter 2024 Financial Results and
Provide Clinical Strategy Update on Tuesday, May 14, 2024
Aptose Reports Results for the Fourth Quarter and Full Year 2023
26 mars 2024 16h01 HE
|
Aptose Biosciences, Inc.
Aptose Reports Results for the Fourth Quarter and Full Year 2023
Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
18 mars 2024 16h30 HE
|
Aptose Biosciences, Inc.
Aptose to Report Fourth Quarter and Year End 2023 Financial Results and
Provide Corporate Update on Tuesday, March 26, 2024
IT Asset Disposition (ITAD) Market Size Projected to Reach USD 32,355.70 Million, Projecting 8.5% CAGR by 2032: Polaris Market Research
02 févr. 2024 08h54 HE
|
Polaris Market Research & Consulting LLP
New York, NY, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The latest research report [115+] pages with 360-degree visibility, titled “IT Asset Disposition (ITAD) Market Share, Size, Trends, Industry Analysis...
Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option
31 janv. 2024 16h01 HE
|
Aptose Biosciences, Inc.
Aptose closes previously announced public offering and private placement